AdipoRon is an oral AdipoR1/R2 agonist that successfully reestablished adiponectin functions, mainly activating AMPK and PPAR-α pathways, in obesity-related type 2 diabetes [164]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.